These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 June. The technology gains life-saving medical insights by analysing human excrement. Ụlọ ọrụ ahụ etinyela akwụkwọ ikike atọ nke na-ekpuchi ihe nke ihe mmetụta ụlọ mposi ahụike ya.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Europe, Japan na China.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, Teknụzụ OutSense nwere ike ịchọpụta isi iyi nke ọbara n'akụkụ eriri afọ.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

Dabere na OutSense CEO Yfat Scialom, who predicts that “na mgbawa nke ọgwụ dijitalụ, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, ọrịa afọ ntachi na ọrịa urinary tract.

Its solution consists of a multispectral optical sensor, isi iyi ọkụ na ngwaọrụ nyocha kwụụrụ onwe nke gụnyere njikọ WiFi. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Ozi enwetara site na ọbara a nwapụtara, jikọtara ya na nyocha ndị ọzọ nke oge site na ọbara ọgbụgba na-apụ apụ, na-enye nkọwa nke pathology ọbara ọgbụgba. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense kwuputara na CommuniCare, nnukwu ụlọ ọrụ ahụike nwere ihe karịrị 90 healthcare facilities in the US, ga-amalite ịnya ụgbọ elu teknụzụ ya n'afọ a. Na mgbakwunye na nke a pilot, OutSense also plans to conduct clinical trials in Israel and Japan.

Visit More News at Viga.cc News